Imofinostat is an investigational new drug that is being developed by Formosa Pharmaceuticals and Anbogen Therapeutics for the treatment of colorectal cancer. It is a histone deacetylase inhibitor with selectivity for HDAC3.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.